This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Jamp-Quinine (2014-11-21)

Starting date:
November 21, 2014
Posting date:
December 12, 2014
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-42893

Recalled Products

  1. Jamp-Quinine 200 mg
  2. Jamp-Quinine 300 mg

Reason

The product was recalled following the addition of quinine or its salts or derivatives to the Prescription Drug List.

Depth of distribution

Wholesalers and Retailers

Affected products

A. Jamp-Quinine 200 mg

DIN, NPN, DIN-HIM
NPN 80040279
Dosage form

Capsule

Strength

200 mg

Lot or serial number

100 caps Format:

  • (L) 26292
  • (L) 27459

500 caps Format:

  • (L) 26292
  • (L) 27459
Companies
Recalling Firm
Jamp Pharma Inc.
1380-203 Newton Street
Boucherville
J4B 5H2
Quebec
CANADA
Marketing Authorization Holder
Jamp Pharma Inc.
1380-203 Newton Street
Boucherville
J4B 5H2
Quebec
CANADA

B. Jamp-Quinine 300 mg

DIN, NPN, DIN-HIM
NPN 80040277
Dosage form

Capsule

Strength

300 mg

Lot or serial number

100 caps Format: (L) 26293, (L) 27460
500 caps Format: (L) 26293, (L) 27460

Companies
Recalling Firm
Jamp Pharma Inc.
1380-203 Newton Street
Boucherville
J4B 5H2
Quebec
CANADA
Marketing Authorization Holder
Jamp Pharma Inc.
1380-203 Newton Street
Boucherville
J4B 5H2
Quebec
CANADA

Date modified: